BioCentury
ARTICLE | Clinical News

Zorvolex lower dose submicron diclofenac regulatory update

September 8, 2014 7:00 AM UTC

FDA approved an sNDA from Iroko for Zorvolex to treat osteoarthritis pain in adults. The product is approved in the U.S. to treat mild to moderate acute pain in adults. Iroko launched Zorvolex in January. ...